
Daiichi Sankyo is EMBL’s newest Corporate Partnership Programme associate partner.
The fundamental research of many EMBL scientists has important implications for drug development. Daiichi Sankyo is specifically exploring ways to collaborate on this.
embl.org/news/embl-anno…

English















